期刊文献+

肿瘤标志物CEA、NSE、CA211和SCC在肺癌诊断中的临床意义 被引量:14

Clinical Significance of CEA,NSC,CA211 and SCC in the Diagnosis of Lung Cancer
暂未订购
导出
摘要 目的探讨血清肿瘤标志物(TMs)癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、糖原211(CA211)、鳞状细胞相关抗原(SCC)联合检测在肺癌诊断中的价值。方法应用化学发光免疫法检测103例肺癌组、30例肺部良性肿块组和50例正常对照组患者血清中CEA、NSE、CA211和SCC4种TMs的浓度。结果肺癌组与良性肿块组和健康对照组中的4种TMs含量比较均有统计学意义(P<0.05),良性肿块组与健康对照组比较均无统计学意义(P>0.05)。CEA在肺腺癌中表达阳性率明显增高;SCC、CA211在肺鳞癌和腺癌中表达阳性率明显增高;NSE在小细胞肺癌中表达阳性率明显增高。CEA+CA211+NSE组合用于检测肺癌时的阳性率明显高于其他组合。结论血清CEA、NSE、CA211和SCC在肺癌诊断中具有重要意义,CEA+CA211+NSE组合联合检测诊断不同病理分型的肺癌阳性率最高。 Objective To evaluate the clinical value of combined detection of serum carcinoembryonic antigen (CEA) , neuro - specific enolase (NSE) , carbohydrate antigen 211 (CA211 ) and squamous cell carcinoma associated antigen (SCC) in patients with lung cancer. Methods The CEA, NSE, CA211 and SCC contents were detected in 103 lung cancer patients, 30 benign lung mass patients and 50 controls by chemiluminescence immunoassay. Results The concentrations of the four tumor markers in lung cancer group were significantly different from those in benign lung mass group and control group ( P 〈 0.05 ) , but in benign lung mass group they were same as those in control group ( P 〉 0.05). The positive expression rate of CEA increased significantly in lung adenocarcinoma, and SCC and CA211 in lung squamous cell carcinoma and lung adenocarcinoma, while NSE in small cell lung cancer. The positive percentage of the combination of CEA + CA211 + NSE in lung cancer was higher than the other combinations. Conclusion Serum CEA, NSE, CA211 and SCC are helpful for the diagnosis of lung cancer, and the positive percentage of the combination of CEA + CA211 + NSE in lung cancer was the highest level.
出处 《医学研究杂志》 2010年第11期72-74,共3页 Journal of Medical Research
  • 相关文献

参考文献6

  • 1Herbst RS,Heymach JV,Lippman SM.Lung cancer.N Engl J Med,2008,359(13):1367-1380.
  • 2Stieber P,Hasholzner U,Bodenmuller H,et al.CYFRA21-1.A new marker in lung cancer.Cancer,1993,72(3):707-713.
  • 3董卫,马传栋.肿瘤诊断试验论著质量的初步评价[J].中华肿瘤杂志,2001,23(1):28-30. 被引量:14
  • 4Hotta K,Segawa Y,Takigawa N,et al.Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.Anticancer Res,2000,20(3B):2177-2180.
  • 5程黎明,邓玲艳,管青.评价CYFRA21-1、NSE和CEA对非小细胞肺癌的诊断价值[J].中国实验诊断学,2009,13(4):489-492. 被引量:33
  • 6Ho YJ,Hsieh JF,Tasi SC,et al.Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma.Lung,2000,178(2):75-80.

二级参考文献6

  • 1Molina R, Filella X, Auge JM, et al. Tumor markers ( cea, ca 125, cyfra 21-1 ,scc and nse) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors[ J]. Tumour Biol, 2003,24 : 209.
  • 2Pastor A, Menendez R, Cremades M.I, et al. Diagnostic value of scc, cea and cyfra 21.1 in lung cancer: A bayesian analysis[J]. Eur Respir J, 1997,10:603.
  • 3Maeda T, Ueoka H, Tabata M, et al. Prognostic factors in advanced nonsmall cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis[ J]. Jpn J Clin Oncol, 2000,30: 534.
  • 4Kulpa J, Wojcik E, Reinfuss M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, cyfra 21-1, and neuron-specific enolase in squamous cell lung cancer patients[J]. Clin Chem,2002,48:1931.
  • 5Wieskopf B, Demangeat C, Purohit A, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role[J]. Chest, 1995,108 : 163.
  • 6毛宗福,丁元林.临床诊断试验论著质量分析[J].中华医院管理杂志,1998,14(2):105-106. 被引量:17

共引文献44

同被引文献133

引证文献14

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部